Accovion GmbH Report issue

For profit Phase 3 Phase 4
Founded: Eschborn Germany (2001)
Status: Acquired by Clinipace LTD (2015)

Organization Overview

First Clinical Trial
2008
NCT02799069
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (2)

diclofenac (voltaren) (1 trial)

imiquimod (aldara) (1 trial)

Drugs in Phase 3 Trials (2)

aminolevulinic acid (levulan) (2 trials)

methyl aminolevulinate (metvixia) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 3)

Carcinoma, Basal Cell (Phase 3)

Keratosis (Phase 4)

Keratosis, Actinic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4